HILLEVAX INC (HLVX) Stock Income Statement
NASDAQ:HLVX - US43157M1027 - Common Stock
2.095 USD
0 (-0.24%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 52.35M | 106.96M | 133.34M | 65.11M | 53.43M | |||
| Research and Development | 28.90M | 78.17M | 106.68M | 48.41M | 47.67M | |||
| Selling, General, and Administrative Expenses | 23.44M | 28.79M | 26.66M | 16.71M | 5.76M | |||
| Operating Income | -52.35M | -106.96M | -133.34M | -65.11M | -53.43M | |||
| Interest Income/Expense | 4.48M | 5.59M | 7.31M | 460.00K | -2.84M | |||
| Other Income/Expense | 3.40M | 4.29M | 2.46M | -95.16M | -46.14M | |||
| Non Recurring Items | -26.63M | -50.19M | 0.00 | N/A | N/A | |||
| Income Before Taxes | -71.10M | -147.27M | -123.57M | -159.81M | -102.41M | |||
| Net Income | -71.10M | -147.27M | -123.57M | -159.81M | -102.41M | |||
| EBITDA | -49.68M | -103.76M | -131.19M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.43 | -3.00 | -3.04 | -5.89 | -3.23 | |||
| Non GAAP EPS | -1.43 | -3.00 | -3.04 | -13.10 | N/A | |||
| Statistics | ||||||||
All data in USD